Page 914 - Adams and Stashak's Lameness in Horses, 7th Edition
P. 914
880 Chapter 8
64. Shoji KE, Earp BE, Rozental TD. The effect of bisphosphonates on 68. Todhunter RJ, Lust G. Polysulfated glycosaminoglycan in the treat-
the clinical and radiographic outcomes of distal radius fractures in 69. Trotter GW, Yovich JV, McIlwraith CW, et al. Effects of intramuscu-
ment of osteoarthritis. J Am Vet Med Assoc 1994;204:1245–1251.
women. J Hand Surg Am 2018;43:115–122. doi:10.1016/j.jhsa.
VetBooks.ir 65. Smith GN Jr, Mickler EA, Hasty KA, et al. Specificity of inhibition 70. Vacha J, Pesakova V, Krajickova J, et al. Effect of glycosaminogly-
lar polysulfated glycosaminoglycan on chemical and physical defects
2017.09.006.
in equine articular cartilage. Can J Vet Res 1989;53:224–230.
of matrix metalloproteinase activity by doxycycline: relationship
to structure of the enzyme. Arthritis Rheum 1999;42:1140–1146.
Arzneimittelforschung 1984;34:607–609.
doi:10.1002/1529‐0131(199906)42:6<1140::AID‐ can polysulphate on the metabolism of cartilage ribonucleic acid.
ANR10>3.0.CO;2‐7. 71. Villarreal FJ, Griffin M, Omens J, et al. Early short‐term treatment
66. Tamoto K, Tada M, Shimada S, et al. Effects of high‐molecular‐ with doxycycline modulates postinfarction left ventricular remod-
weight hyaluronates on the functions of guinea pig polymorpho- eling. Circulation 2003;108:1487–1492. doi:10.1161/01.
nuclear leukocytes. Semin Arthritis Rheum 1993;22:4–8. CIR.0000089090.05757.34.
67. Tanabe M, Takasu K, Kasuya N, et al. Role of descending noradr- 72. Yu LP Jr, Smith GN Jr, Brandt KD, et al. Reduction of the severity
energic system and spinal alpha2‐adrenergic receptors in the of canine osteoarthritis by prophylactic treatment with oral doxy-
effects of gabapentin on thermal and mechanical nociception after cycline. Arthritis Rheum 1992;35:1150–1159.
partial nerve injury in the mouse. Br J Pharmacol 2005;144:703–
714. doi:10.1038/sj.bjp.0706109.